Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient

Details for Australian Patent Application No. 2008310481 (hide)

Owner Taiho Pharmaceutical Co., Ltd.

Inventors Sakamoto, Kazuki; Nakagawa, Fumio

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008310481

PCT Pub. Number WO2009/047904

Priority 2007-265339 11.10.07 JP

Filing date 10 October 2008

Wipo publication date 16 April 2009

International Classifications

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/047904 Priority application(s): WO2009/047904

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008310483-Air conditioner

2008310480-Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient